T1	Qualifier 20 29	untreated
T2	Qualifier 0 15	Newly diagnosed
T3	Measurement 30 42	sputum smear
T4	Value 43 51	positive
T5	Condition 52 64	tuberculosis
R1	Has_value Arg1:T3 Arg2:T4	
*	OR T1 T2
R2	AND Arg1:T5 Arg2:T3	
T6	Scope 0 29	Newly diagnosed and untreated
R3	Has_scope Arg1:T5 Arg2:T6	
T7	Condition 74 90	Pulmonary lesion
T8	Condition 107 109	TB
T9	Procedure 113 137	radiological examination
T10	Qualifier 91 109	consistent with TB
R4	multi Arg1:T10 Arg2:T8	
R5	Has_qualifier Arg1:T7 Arg2:T10	
R6	AND Arg1:T9 Arg2:T7	
T11	Value 139 147	Positive
T12	Measurement 148 162	sputum culture
R7	Has_value Arg1:T12 Arg2:T11	
T13	Condition 207 233	Mycobacterium tuberculosis
T14	Qualifier 182 196	bacterial type
R8	Has_qualifier Arg1:T13 Arg2:T14	
T15	Measurement 235 267	MGIT drug sensitivity test (DST)
T16	Value 280 366	sensitive of the first-line drugs (isoniazid, streptomycin, rifampicin and ethambutol)
T17	Drug 297 313	first-line drugs
T18	Drug 315 324	isoniazid
T19	Drug 326 338	streptomycin
T20	Drug 340 350	rifampicin
T21	Drug 355 365	ethambutol
*	OR T21 T20 T19 T18
T22	Scope 315 365	isoniazid, streptomycin, rifampicin and ethambutol
R9	Subsumes Arg1:T17 Arg2:T22	
R10	AND Arg1:T15 Arg2:T17	
T23	Person 369 372	Age
T24	Value 373 394	18 years-65 years old
R11	Has_value Arg1:T23 Arg2:T24	
T25	Person 396 401	Males
T26	Negation 405 409	non-
T27	Condition 409 417	pregnant
T28	Negation 419 423	non-
T29	Observation 423 430	nursing
T30	Person 431 438	females
T31	Scope 405 438	non-pregnant, non-nursing females
*	OR T31 T25
R12	Has_negation Arg1:T27 Arg2:T26	
R13	Has_negation Arg1:T29 Arg2:T28	
T32	Measurement 449 473	plasma aminotransferases
T33	Measurement 475 478	AST
T34	Measurement 480 483	ALT
T35	Measurement 440 445;456 473	Serum aminotransferases
*	OR T32 T35
*	OR T33 T34
T36	Scope 440 473	Serum or plasma aminotransferases
T37	Scope 475 483	AST, ALT
R14	Subsumes Arg1:T36 Arg2:T37	
T38	Value 485 528	less than 3 times the upper limit of normal
R15	Has_value Arg1:T36 Arg2:T38	
T39	Qualifier 539 545	plasma
T40	Qualifier 530 535	Serum
T41	Measurement 546 561	total bilirubin
*	OR T39 T40
T42	Value 562 619	less than or equal to 2.5 times the upper limit of normal
T43	Scope 530 545	Serum or plasma
R16	Has_scope Arg1:T41 Arg2:T43	
R17	Has_value Arg1:T41 Arg2:T42	
T44	Qualifier 630 636	plasma
T45	Qualifier 621 626	Serum
T46	Measurement 637 653	creatinine level
T47	Value 654 709	less than or equal to 2 times the upper limit of normal
*	OR T44 T45
T48	Scope 621 636	Serum or plasma
R18	Has_scope Arg1:T46 Arg2:T48	
R19	Has_value Arg1:T46 Arg2:T47	
T49	Qualifier 711 716	Serum
T50	Qualifier 720 726	plasma
T51	Measurement 727 742	potassium level
T52	Value 743 777	greater than or equal to 3.5 meq/L
*	OR T50 T49
T53	Scope 711 726	Serum or plasma
R20	Has_scope Arg1:T51 Arg2:T53	
R21	Has_value Arg1:T51 Arg2:T52	
T54	Measurement 779 795	Hemoglobin level
T55	Value 799 818	7.0 g/dL or greater
R22	Has_value Arg1:T54 Arg2:T55	
T56	Measurement 820 834	Platelet count
T57	Value 838 860	100,000/mm3 or greater
R23	Has_value Arg1:T56 Arg2:T57	
T58	Person 866 871	women
T59	Observation 875 897	childbearing potential
T60	Value 901 909	negative
T61	Measurement 910 924	pregnancy test
T62	Scope 866 897	women of childbearing potential
A1	Optional T62
R24	Has_value Arg1:T61 Arg2:T60	
T63	Temporal 937 953	during screening
T64	Reference_point 944 953	screening
R25	Has_index Arg1:T63 Arg2:T64	
R26	Has_temporal Arg1:T61 Arg2:T63	
R27	AND Arg1:T62 Arg2:T61	
T65	Observation 964 988	written informed consent
T66	Observation 1006 1050	ability to attend scheduled follow-up visits
T67	Observation 1006 1016;1055 1080	ability to undergo study assessments
T68	Observation 1014 1050;990 1001	to attend scheduled follow-up visits Willingness
T69	Observation 1014 1016;1055 1080;990 1001	to undergo study assessments Willingness
